Literature DB >> 11243390

Remission of severe cold agglutinin disease after Rituximab therapy.

N Layios, E Van Den Neste, E Jost, V Deneys, J M Scheiff, A Ferrant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11243390     DOI： 10.1038/sj.leu.2401976

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Remission of cold hemagglutinin disease induced by rituximab therapy.

Authors:  T G Sparling; M Andricevic; H Wass
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

Review 2.  Monoclonal antibodies in the treatment of chronic lymphocytic leukemia.

Authors:  Nina Shih Liu; Susan O'Brien
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

3.  Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas.

Authors:  Claudio Fozza; Maurizio Longinotti
Journal:  Adv Hematol       Date:  2011-04-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.